Supplementary Material
Figure S2
LNCaP, PC-3 and 22Rv1 cells were cultured in medium containing 5% FBS. LNCaP95 cells were in medium containing 5% charcoal stripped serum (CSS). (A). LNCaP95, LNCaP and 22Rv1 cells were treated with 0, 1, 2, and 5μM of tautomycetin (TMC) for 0-24 hours. AR-FL, AR-v7 and -actin protein levels were measured by Western blotting. (B) PC3(AR-FL) and PC3(AR-v7) cells and (C) LNCaP cells were treated with 50μg/ml cycloheximide (CHX) plus either vehicle or 5μM of TMC for 0-24 hours. AR-FL and AR-v7 protein levels were measured by Western blotting. Densitometry analyses of AR-FL and AR-v7 levels were normalized to -actin. Results were from triplicate experiments. Data in line graphs represent means ± SD.
Figure S3
LNCaP cells were cultured in medium containing 5% FBS, while LNCaP95 cells were in medium containing 5% charcoal stripped serum (CSS). LNCaP and LNCaP95 cells were treated with 0, 2, 5μM of TMC (A, B, E and F) or transfected with expression vector of control, PP-1 or PP-1(H125A) (C, D, G and H) for 24 hours. Real-time PCR measured AR-FL and AR-v7 mRNA levels relative to 18S (A-D). Real-time PCR measured AR-FL splicing (E and G) and AR-v7 splicing (F and H) rates relative to all AR transcripts. Primers were designed to cover the junctions of exons 3 and 4 for AR-FL, exons 3 and 3b for AR-v7 and exons 2 and 3 for total AR transcripts. Results were from three independent experiments. Data in line graphs represent means ± SD. 293T and PC-3 cells were cultured in medium containing 5% FBS. 293T cells were transfected with AR-FL (A and C) plasmid. PC3 cells were stably introduced AR-FL (B). Both cell lines were culture in medium containing 5% FBS. Cells were co-transfected with either control or PP-1 plasmid (A), or treated with vehicle or 5μM of TMC (B) or transfected with dAkt or cAkt expression vector for 24 hours (C). Cells were also treated with 2μg/ml of MG132 for another 16 hours. Cytoplasmic and nuclear fractions of protein lysis were extracted. Histone 3 (H3) and tubulin were detected by Western blotting and used as markers to confirm the efficacy of the nuclear fraction extraction. In vivo ubiquitination assays were performed as described in Material and Method section. All experiments were repeated at least three times with one set of results shown in the figure. 
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